1. Home
  2. TISI vs CRVO Comparison

TISI vs CRVO Comparison

Compare TISI & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TISI
  • CRVO
  • Stock Information
  • Founded
  • TISI 1973
  • CRVO 2001
  • Country
  • TISI United States
  • CRVO United States
  • Employees
  • TISI N/A
  • CRVO N/A
  • Industry
  • TISI Other Consumer Services
  • CRVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TISI Consumer Discretionary
  • CRVO Health Care
  • Exchange
  • TISI Nasdaq
  • CRVO Nasdaq
  • Market Cap
  • TISI 81.8M
  • CRVO 67.4M
  • IPO Year
  • TISI N/A
  • CRVO N/A
  • Fundamental
  • Price
  • TISI $17.50
  • CRVO $7.79
  • Analyst Decision
  • TISI
  • CRVO Strong Buy
  • Analyst Count
  • TISI 0
  • CRVO 6
  • Target Price
  • TISI N/A
  • CRVO $19.17
  • AVG Volume (30 Days)
  • TISI 7.8K
  • CRVO 109.2K
  • Earning Date
  • TISI 11-10-2025
  • CRVO 11-11-2025
  • Dividend Yield
  • TISI N/A
  • CRVO N/A
  • EPS Growth
  • TISI N/A
  • CRVO N/A
  • EPS
  • TISI N/A
  • CRVO N/A
  • Revenue
  • TISI $870,735,000.00
  • CRVO $7,776,968.00
  • Revenue This Year
  • TISI N/A
  • CRVO N/A
  • Revenue Next Year
  • TISI N/A
  • CRVO N/A
  • P/E Ratio
  • TISI N/A
  • CRVO N/A
  • Revenue Growth
  • TISI 2.55
  • CRVO N/A
  • 52 Week Low
  • TISI $11.12
  • CRVO $1.80
  • 52 Week High
  • TISI $26.77
  • CRVO $19.50
  • Technical
  • Relative Strength Index (RSI)
  • TISI 40.44
  • CRVO 33.57
  • Support Level
  • TISI $17.57
  • CRVO $9.61
  • Resistance Level
  • TISI $19.62
  • CRVO $10.48
  • Average True Range (ATR)
  • TISI 0.85
  • CRVO 0.64
  • MACD
  • TISI -0.20
  • CRVO -0.29
  • Stochastic Oscillator
  • TISI 0.00
  • CRVO 0.96

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: